Key result
This 2021 review highlights key publications on cardiovascular CT, MRI, and PET/CT, emphasizing their roles in stable chest pain, cardiomyopathies, valvular disease, and COVID-19 manifestations.
Why the study?
To summarize key 2021 publications on noninvasive cardiac imaging modalities—cardiac CTA, MRI, and PET/CT—relevant to radiologists in clinical practice.
This review highlights key 2021 publications in cardiovascular imaging, emphasizing the roles of CTA, MRI, and PET/CT in various cardiac conditions.
May guide imaging selection in chest pain and cardiomyopathies; leaves open prospective validation for COVID-19 applications.
This review focuses on three key noninvasive cardiac imaging modalities—cardiac CT angiography (CTA), MRI, and PET/CT—and summarizes key publications in 2021 relevant to radiologists in clinical practice. Although this review focuses primarily on articles published in Radiology, important studies from other major journals are included to highlight “must-know” articles in the field of cardiovascular imaging. Cardiac CTA has been established as the first-line test for patients with stable chest pain and no known coronary artery disease, and its value remains central to the assessment of surgical or transcatheter aortic valve replacement. Artificial intelligence continues to evolve in a number of applications in cardiovascular disease. In cardiac MRI studies, 2021 has seen an emphasis on nonischemic cardiomyopathies, valvular heart disease, and COVID-19 disease cardiac manifestations and the authors highlight the key articles on these topics. A section featuring the increasing role of cardiac PET/CT in the assessment of cardiac sarcoidosis and prosthetic valves is also provided.
No takes yet. Share an insight, caveat, or question.
Τζίμας et al. (2022) conducted a review in Cardiovascular disease. Cardiovascular CT, MRI, and PET/CT was evaluated. This 2021 review highlights key publications on cardiovascular CT, MRI, and PET/CT, emphasizing their roles in stable chest pain, cardiomyopathies, valvular disease, and COVID-19 manifestations.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: